Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Kansas committee hears divided testimony on bill to let pharmacists initiate limited therapies

Committee on House Health and Human Services · February 10, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The House Health and Human Services Committee heard proponent and opponent testimony on House Bill 2,676, which would allow pharmacists to initiate limited therapies (test-and-treat, emergency refills, minor ailments) under a standard-of-care framework. Supporters cited rural access and workforce shortages; medical society raised liability and scope concerns.

The Committee on House Health and Human Services heard testimony on House Bill 2,676, a proposal to allow licensed pharmacists in Kansas to initiate therapy for a narrow set of conditions consistent with their education, training and professional judgment. Reviser Carly summarized the bill’s core provisions, including four categories of pharmacist authority: care that does not require a new diagnosis, minor and generally self-limiting conditions, treatment guided by CLIA-waived tests, and patient emergencies.

Supporters told the committee the measure is a pragmatic response to access challenges in rural and underserved areas. Tim Frost, a licensed pharmacist and senior fellow with Cicero Action, said a standard-of-care approach is already in place in several states and argued the bill does not deregulate the profession. “This is not deregulation. This is…

Already have an account? Log in

Subscribe to keep reading

Unlock the rest of this article — and every article on Citizen Portal.

  • Unlimited articles
  • AI-powered breakdowns of topics, speakers, decisions, and budgets
  • Instant alerts when your location has a new meeting
  • Follow topics and more locations
  • 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans